| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT07496450 A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults |
Enrollment closed, study ongoing |
| 2026-08-12 | NCT07737717 A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469… |
Recruitment opened |
| 2026-08-11 | NCT05683457 A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus… |
date change Primary completion pushed: 2026-08-01 -> 2027-03-06 |
| 2026-08-11 | NCT05683457 A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus… |
date change Completion pushed: 2026-08-01 -> 2027-03-06 |
| 2026-08-11 | NCT06880549 A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer… |
Enrollment reopened |
| 2026-08-06 | NCT05701800 A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in… |
critical Trial terminated |
| 2026-08-06 | NCT05701800 A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in… |
critical Trial terminated: The clinical study was terminated prior to the start of Phase 2 following a business decision to discontinue further de... |
| 2026-08-06 | NCT05701800 A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in… |
Phase changed: Phase 1/2 -> Phase 1 |
| 2026-08-06 | NCT05701800 A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in… |
date change Primary completion moved earlier: 2026-06-30 -> 2025-12-31 |
| 2026-08-06 | NCT05701800 A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in… |
date change Completion moved earlier: 2026-06-30 -> 2025-12-31 |
| 2026-08-04 | NCT07561294 A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to… |
Enrollment closed, study ongoing |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07764237 A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile… | Phase 1 | Not Yet Recruiting |
| 2026-07-30 | NCT07737717 A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06585241 | A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing… | SARS-CoV-2 | Recruiting |
| NCT07266558 | A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50… | SARS-CoV-2 | Active, Not Recruiting |
| Phase 3 | |||
| NCT06067230 | A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting… | Respiratory Syncytial Virus | Active, Not Recruiting |
| NCT06592794 | A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of… | Acute Gastroenteritis | Active, Not Recruiting |
| NCT07496450 | A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults | Influenza | Active, Not Recruiting |
| Phase 2 | |||
| NCT06735248 | A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With… | Multiple Sclerosis | Recruiting |
| NCT03897881 | An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157… | Melanoma | Active, Not Recruiting |
| NCT07561294 | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to… | Lyme Disease | Active, Not Recruiting |
| NCT05683457 | A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus… | Cytomegalovirus Infection | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05295433 | An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in… | Methylmalonic Acidemia | Recruiting |
| NCT04159103 | Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia | Propionic Acidemia | Recruiting |
| NCT05130437 | A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants… | Propionic Acidemia | Recruiting |
| NCT05533697 | Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade… | Advanced Solid Tumors | Recruiting |
| NCT07116616 | A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Multiple Myeloma | Recruiting |
| NCT05095727 | A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease… | Glycogen Storage Disease | Active, Not Recruiting |
| NCT05992935 | Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and… | Norovirus Acute Gastroenteritis | Active, Not Recruiting |
| NCT05164094 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to… | Epstein-Barr Virus Infection | Active, Not Recruiting |
| Phase 1 | |||
| NCT07478952 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18… | Epstein-Barr Virus | Recruiting |
| NCT06880549 | A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer… | Advanced Solid Tumors | Recruiting |
| NCT07737717 | A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469… | Ebola-Bundibugyo Virus Disease (Ebola-BDBV) | Recruiting |
| NCT06655870 | A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously… | Healthy Participants | Active, Not Recruiting |
| NCT03313778 | Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in… | Solid Tumors | Active, Not Recruiting |
| NCT05743881 | A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in… | Respiratory Syncytial Virus | Active, Not Recruiting |
| NCT05831111 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to… | Epstein-Barr Virus Infection | Active, Not Recruiting |
| NCT07764237 | A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile… | Respiratory Syncytial Virus (RSV) | Not Yet Recruiting |